ATE362981T1 - Verbindungen zur hydrolyse von ribonukleinsäuren (rns) - Google Patents
Verbindungen zur hydrolyse von ribonukleinsäuren (rns)Info
- Publication number
- ATE362981T1 ATE362981T1 AT04075764T AT04075764T ATE362981T1 AT E362981 T1 ATE362981 T1 AT E362981T1 AT 04075764 T AT04075764 T AT 04075764T AT 04075764 T AT04075764 T AT 04075764T AT E362981 T1 ATE362981 T1 AT E362981T1
- Authority
- AT
- Austria
- Prior art keywords
- compounds
- rns
- hydrolysis
- ribonucleic acids
- relates
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 229920002477 rna polymer Polymers 0.000 title 2
- 230000007062 hydrolysis Effects 0.000 title 1
- 238000006460 hydrolysis reaction Methods 0.000 title 1
- 238000003776 cleavage reaction Methods 0.000 abstract 1
- 230000003301 hydrolyzing effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 230000007017 scission Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/111—General methods applicable to biologically active non-coding nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/11—Antisense
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/31—Chemical structure of the backbone
- C12N2310/318—Chemical structure of the backbone where the PO2 is completely replaced, e.g. MMI or formacetal
- C12N2310/3181—Peptide nucleic acid, PNA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/35—Nature of the modification
- C12N2310/351—Conjugate
- C12N2310/3511—Conjugate intercalating or cleaving agent
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2330/00—Production
- C12N2330/30—Production chemically synthesised
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04075764A EP1574572B1 (de) | 2004-03-09 | 2004-03-09 | Verbindungen zur Hydrolyse von Ribonukleinsäuren (RNS) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE362981T1 true ATE362981T1 (de) | 2007-06-15 |
Family
ID=34814336
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04075764T ATE362981T1 (de) | 2004-03-09 | 2004-03-09 | Verbindungen zur hydrolyse von ribonukleinsäuren (rns) |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20090233981A1 (de) |
| EP (1) | EP1574572B1 (de) |
| JP (1) | JP2007528224A (de) |
| CN (1) | CN100537763C (de) |
| AT (1) | ATE362981T1 (de) |
| AU (1) | AU2005219815B2 (de) |
| CA (1) | CA2559114A1 (de) |
| DE (1) | DE602004006599T2 (de) |
| DK (1) | DK1574572T3 (de) |
| ES (1) | ES2287634T3 (de) |
| PL (1) | PL1574572T3 (de) |
| WO (1) | WO2005085442A2 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008118013A2 (en) | 2007-03-23 | 2008-10-02 | To-Bbb Holding B.V. | Targeted intracellular delivery of antiviral agents |
| JP5429039B2 (ja) * | 2010-05-17 | 2014-02-26 | 株式会社島津製作所 | 酸加水分解によるｒｎａの分解方法及びそれを用いたｒｎａの配列解析方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5359051A (en) * | 1990-01-11 | 1994-10-25 | Isis Pharmaceuticals | Compounds useful in the synthesis of nucleic acids capable of cleaning RNA |
| JPH07255483A (ja) * | 1994-03-22 | 1995-10-09 | Makoto Komiyama | リボ核酸を切断する方法 |
| CN1162316A (zh) * | 1994-09-02 | 1997-10-15 | 诺瓦蒂斯有限公司 | 用于核糖核酸裂解的寡核苷酸结合物，组合物及方法 |
| JP3658697B2 (ja) * | 1997-01-14 | 2005-06-08 | 独立行政法人科学技術振興機構 | 人工リボヌクレアーゼ及びその製造法 |
-
2004
- 2004-03-09 AT AT04075764T patent/ATE362981T1/de not_active IP Right Cessation
- 2004-03-09 EP EP04075764A patent/EP1574572B1/de not_active Expired - Lifetime
- 2004-03-09 PL PL04075764T patent/PL1574572T3/pl unknown
- 2004-03-09 ES ES04075764T patent/ES2287634T3/es not_active Expired - Lifetime
- 2004-03-09 DE DE602004006599T patent/DE602004006599T2/de not_active Expired - Lifetime
- 2004-03-09 DK DK04075764T patent/DK1574572T3/da active
-
2005
- 2005-03-09 JP JP2007502744A patent/JP2007528224A/ja active Pending
- 2005-03-09 CN CNB2005800078325A patent/CN100537763C/zh not_active Expired - Fee Related
- 2005-03-09 WO PCT/NL2005/000176 patent/WO2005085442A2/en not_active Ceased
- 2005-03-09 CA CA002559114A patent/CA2559114A1/en not_active Abandoned
- 2005-03-09 AU AU2005219815A patent/AU2005219815B2/en not_active Ceased
- 2005-03-09 US US10/592,175 patent/US20090233981A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| ES2287634T3 (es) | 2007-12-16 |
| DK1574572T3 (da) | 2007-09-24 |
| DE602004006599T2 (de) | 2008-01-31 |
| CN1946845A (zh) | 2007-04-11 |
| AU2005219815A1 (en) | 2005-09-15 |
| PL1574572T3 (pl) | 2007-10-31 |
| WO2005085442A2 (en) | 2005-09-15 |
| JP2007528224A (ja) | 2007-10-11 |
| EP1574572B1 (de) | 2007-05-23 |
| US20090233981A1 (en) | 2009-09-17 |
| EP1574572A1 (de) | 2005-09-14 |
| AU2005219815B2 (en) | 2009-08-20 |
| DE602004006599D1 (de) | 2007-07-05 |
| CA2559114A1 (en) | 2005-09-15 |
| WO2005085442A3 (en) | 2006-01-05 |
| CN100537763C (zh) | 2009-09-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE453716T1 (de) | Verfahren zur modulation der genexpression durch änderung des cpg gehalts | |
| DE60223299D1 (de) | Verfahren zur Sequenzierung von Nukleinsäuren | |
| DE602005027700D1 (de) | Verfahren zur nukleinsäureimmobilisierung | |
| ATE532888T1 (de) | Verfahren zur elektrochemischen spaltung von lignin an einer diamantelektrode | |
| ATE475419T1 (de) | Verfahren zur zubereitung von lansoprazol | |
| DE602005001156D1 (de) | Verfahren und vorrichtung zur reinigung von nukleinsäuren | |
| ATE491809T1 (de) | Amplifikation von dna-fragmenten | |
| DE602004023631D1 (de) | Verfahren zur einführung einer nukleinsäure | |
| ATE495286T1 (de) | Verfahren zur hydrolyse von polyphosphorsäure in polyareneazolfasern | |
| DE60119533D1 (de) | Verfahren zur erkennung des produkts einer nukleinsäuresynthetisierungsreaktion | |
| DE602005008146D1 (de) | Methode für die Quantifizierung der Ausgangs-Konzentration von Nukleinsäuren ausgehend von real-time Amplifikationsdaten | |
| DE602004026253D1 (de) | Verfahren zur Herstellung von Stahlbrammen mit ultra-geringem Kohlenstoffgehalt | |
| ATE407939T1 (de) | 2ß-NITROBENZYL-MODIFIZIERTE RIBONUKLEOTIDE | |
| DE602004006599D1 (de) | Verbindungen zur Hydrolyse von Ribonukleinsäuren (RNS) | |
| DE502004001216D1 (de) | Verfahren zur aufreinigung von blausäure | |
| DE602005015222D1 (de) | Verfahren zur verbesserung der genexpression in pflanzen | |
| DE50204680D1 (de) | Verfahren zur detektion von nukleinsäuremolekülen | |
| DE602006015907D1 (de) | Verfahren zur reinigung von factor vii | |
| EP1960416A4 (de) | Verfahren zur aufreinigung von chenodesoxycholsäure | |
| DE602007009393D1 (de) | Verfahren zur verstärkung durch räumlich-zeitliche frequenzumsetzung und einrichtung zum ausführen des verfahrens | |
| DE602006008770D1 (de) | Verfahren zur hydrolyse von polyphosphorsäure in geformten artikeln | |
| ATE487798T1 (de) | Verfahren zur identifizierung biologisch aktiver strukturen mikrobieller erreger | |
| ATE553194T1 (de) | Verfahren zur dipeptidherstellung | |
| DE50305376D1 (de) | Verfahren zur hydrolyse von carotinoidestern | |
| DE50310774D1 (de) | Verfahren zur Regelung des Fahrverhaltens zur Vermeidung des Untersteuerns |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |